[Skip to Content]
[Skip to Content Landing]
August 7, 1967


JAMA. 1967;201(6):477-478. doi:10.1001/jama.1967.03130060151018

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


One thing is sure about continuing medical education; everybody's now in the act. The players earliest on stage were the medical schools, the various medical societies, the voluntary health agencies, and the manufacturers of prescription drugs. They have been joined rather recently by agencies of the federal government (and that means everybody).

Two of the more interesting roles are being played by the US Public Health Service and the Food and Drug Administration. The former is administering PL 89-239—"the Regional Medical Programs" law that had its origin in the "Report of the President's Commission on Heart Disease, Cancer, and Stroke." The FDA came center stage with regulations deriving from the 1962 amendments to the Food, Drug and Cosmetics Act. The Administration has proclaimed that advertisements are educational, not merely promotional, has written or caused to be written a number of "Dear Doctor" letters, has entered the publishing field with a